CTRI/2016/10/007356招募中1 期
Phase 1 trial of poly (lactide-co-glycolide( (PLG) nanoparticles encapsulating antitubercular drugs (isoniazid, rifmapicin, pyrazinamide and ethambutol).
DRUGS AND PHARMACEUTICALS RESEARCH PROGRAMME or DPRP0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Within 20% of ideal weight
- •Willing to give written informed consent
- •Medical history, physical examination, routine hematology, clinical chemistry, HIV, urinalysis, visual acuity and stool examination for occult blood
排除标准
- •Smokers, alcoholics or taking any drugs of abuse
- •Known contraindication to any of the study drugs
- •HIV / HBsAg positive individuals
- •Participated in any IND study within the previous 6 months or in a confirmatory trial in the previous 3 months
研究者
相似试验
已完成
不适用
Clinical trial to investigate the extent of P-glycoprotein inhibition after oral administration of HM30181A in healthy male subjects: An open, single sequence, 4-period crossover within dose group, parallel dose group desigNeoplasmsKCT0000983Hanmi Pharm18
进行中(未招募)
1 期
Phase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of children and young adult with relapsed/refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/refractory B-cell Acute Lymphoblastic LeukemiaCTIS2023-508420-36-00Ospedale Pediatrico Bambino Gesu'24
已完成
不适用
A phase 1 trial to assess P-gp mediated drug interactions with ASTX660 in healthy volunteerslymphomaadvanced solid tumors10024324acute myeloid leukemiaNL-OMON50115Astex Pharmaceuticals, Inc.48
已完成
不适用
Clinical trial of methoxy polyethylene glycol-epoetin beta (MIRCERA) for renal anemia with chronic heart failureRenal anemia with chronic heart failureJPRN-UMIN000025419Sekino Hospital60
已完成
1 期
Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic PatientsDiabetes Mellitus, Type 2NCT00935220Boehringer Ingelheim41
